The team at Freshfields Bruckhaus Deringer is well-regarded for its capabilities handling prominent patent litigation cases of ultra-high-value for its clients, particularly those in the pharma and consumer healthcare industry sectors. Advising on patent-related aspects of significant corporate transactions is also an area of experience of the team. Rutger Kleemans helms the group and is described by clients as a ‘killer patent lawyer’ with experience acting before domestic and pan-European courts, including the UPC. Jelle Drok handles mass patent claims, ’clever lawyer with a helicopter perspective’ Ruben Laddé became counsel in May 2024 and Allard van Duijn is also a key contact.
Testimonials
Collated independently by Legal 500 research team.
‘A very good, well-coordinated team. All topics are well explained. Their responsiveness is particularly noteworthy.’
‘We worked with Rutger Kleemans and Allard van Duijn. They both provided excellent support and were always approachable. Very experienced team with great strategic thinking.’
Key clients
- Moderna
- Novartis (Sandostatin)
Work highlights
- Representing Moderna in the Dutch litigation against Pfizer and BioNTech as regards their COVID-19 mRNA vaccine (Comirnaty), and coordinating all ex-US matters in this dispute.
- Representing Novartis in Dutch nullity proceedings initiated by Synthon against Novartis’ foundational patent protecting their blockbuster drug used for the indications of heart failure and hypertension (Entresto).